{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:14:24Z","timestamp":1783980864172,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,2]],"date-time":"2016-01-02T00:00:00Z","timestamp":1451692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","e-jmii.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.jmii.2015.06.003","type":"journal-article","created":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T13:41:33Z","timestamp":1435758093000},"page":"677-683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems"],"prefix":"10.1016","volume":"50","author":[{"given":"Chia-Hsin","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Yi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Jr","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Chang","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Jing","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Hsin","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hsun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2015.06.003_bib1","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1086\/591698","article-title":"The impact of antimicrobial resistant, health care-associated infections on mortality in the United States","volume":"47","author":"Klevens","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2015.06.003_bib2","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/377200","article-title":"Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome","volume":"37","author":"Kang","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2015.06.003_bib3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.jinf.2009.02.010","article-title":"Clinical impact of imipenem-resistant Pseudomonas aeruginosa bloodstream infections","volume":"58","author":"Su\u00e1rez","year":"2009","journal-title":"J Infect"},{"key":"10.1016\/j.jmii.2015.06.003_bib4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.diagmicrobio.2004.03.014","article-title":"Molecular epidemiology of selected multidrug-resistant bacteria: a global report from the SENTRY Antimicrobial Surveillance Program","volume":"49","author":"Deshpande","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2015.06.003_bib5","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jcrc.2009.03.006","article-title":"Imipenem-resistant Pseudomonas aeruginosa infection at a medical-surgical intensive care unit: risk factors and mortality","volume":"24","author":"Furtado","year":"2009","journal-title":"J Crit Care"},{"key":"10.1016\/j.jmii.2015.06.003_bib6","doi-asserted-by":"crossref","first-page":"982","DOI":"10.3346\/jkms.2008.23.6.982","article-title":"Imipenem-resistant Pseudomonas aeruginosa: risk factors for nosocomial infections","volume":"23","author":"Onguru","year":"2008","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jmii.2015.06.003_bib7","first-page":"1","article-title":"Pseudomonas aeruginosa bacteremia: associations with a source of infection and antibiotic resistance","volume":"45","author":"Dambrauskiene","year":"2009","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.jmii.2015.06.003_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1089\/mdr.2009.0875","article-title":"Carbapenem resistance mechanism and risk factors of Pseudomonas aeruginosa clinical isolates from a University Hospital in Xi'an, China","volume":"5","author":"Zhang","year":"2009","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jmii.2015.06.003_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.diagmicrobio.2007.05.006","article-title":"Prevalence, mechanisms, and risk factors of carbapenem resistance in bloodstream isolates of","volume":"58","author":"Tam","year":"2007","journal-title":"Pseudomonas aeruginosa. Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2015.06.003_bib10","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1128\/AAC.00810-07","article-title":"Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals","volume":"51","author":"Guti\u00e9rrez","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2015.06.003_bib11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1128\/AAC.31.5.703","article-title":"Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein","volume":"31","author":"B\u00fcscher","year":"1987","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2015.06.003_bib12","series-title":"Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"10.1016\/j.jmii.2015.06.003_bib13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1089\/mdr.2014.0116","article-title":"Reduced production of OprM may promote oprD mutations and lead to imipenem resistance in Pseudomonas aeruginosa carrying an oprD-Group 1A allele","volume":"21","author":"Shu","year":"2015","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jmii.2015.06.003_bib14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/SHK.0b013e318182f98f","article-title":"Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems","volume":"31","author":"Rhee","year":"2009","journal-title":"Shock"},{"key":"10.1016\/j.jmii.2015.06.003_bib15","first-page":"647","article-title":"Imipenem-resistant Pseudomonas aeruginosa bacteremia in cancer patients: risk factors, clinical features and outcome","volume":"97","author":"Krcm\u00e9ry","year":"1996","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.jmii.2015.06.003_bib16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jhin.2004.09.007","article-title":"Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients","volume":"59","author":"Zavascki","year":"2005","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jmii.2015.06.003_bib17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1086\/338237","article-title":"Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients","volume":"34","author":"Harris","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2015.06.003_bib18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/mdr.2010.0170","article-title":"Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia: clinical impact of antimicrobial resistance on outcome","volume":"17","author":"Joo","year":"2011","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.jmii.2015.06.003_bib19","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3390\/medicina46070071","article-title":"Pseudomonas aeruginosa bacteremia: resistance to antibiotics, risk factors, and patient mortality","volume":"46","author":"Vitkauskien\u0117","year":"2010","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.jmii.2015.06.003_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1086\/649021","article-title":"Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes","volume":"31","author":"Lautenbach","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jmii.2015.06.003_bib21","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/j.ijid.2009.11.019","article-title":"Influence of carbapenem resistance on mortality and the dynamics of mortality in Pseudomonas aeruginosa bloodstream infection","volume":"14","author":"Su\u00e1rez","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jmii.2015.06.003_bib22","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1128\/AAC.47.9.2756-2764.2003","article-title":"Effectiveness of combination antimicrobial therapy for Pseudomonas aeruginosa bacteremia","volume":"47","author":"Chamot","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jmii.2015.06.003_bib23","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1128\/AAC.49.4.1306-1311.2005","article-title":"Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment","volume":"49","author":"Micek","year":"2005","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118215007677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118215007677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T22:10:47Z","timestamp":1566943847000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118215007677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S1684118215007677"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2015.06.003","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2015.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}